# Smoflipid

NDC: 63323-820
Generic name: Smoflipid
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, EMULSION
Routes: INTRAVENOUS
Marketing started: 20160713

FDA application: NDA207648

## Active ingredients

- FISH OIL: 3 g/100mL
- MEDIUM-CHAIN TRIGLYCERIDES: 6 g/100mL
- OLIVE OIL: 5 g/100mL
- SOYBEAN OIL: 6 g/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0e9d917-ff6f-488e-a6a8-0ad59dd17d80